A rat study in Bioelectromagnetics examined GSM-modulated 3.5 GHz RF-EMF exposure (2 h/day for 30 days) and reported adverse changes in male reproductive hormones, oxidative stress markers, and testicular histology. The authors also tested Coenzyme Q10 (CoQ10) and found it partially ameliorated some RF-associated alterations. The paper notes that because the exposure used a GSM-modulated waveform, findings cannot be extrapolated to FR1 5G NR signals, and calls for further research under real-world conditions.

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

RF Safe reports that HHS confirmed plans to launch a new study on cellphone radiation and that an HHS spokesperson said the FDA removed webpages with “old conclusions” while new research is undertaken to identify knowledge gaps, including for emerging technologies. The article frames the FDA webpage changes as a meaningful shift away from categorical reassurance, while noting Reuters’ reporting that some FDA and CDC pages still state there is no credible evidence of health problems from cellphone radiation. It also links the development to the 2021 D.C. Circuit decision in Environmental Health Trust v. FCC, arguing the ruling exposed weaknesses in the FCC’s reliance on other agencies’ statements.

RF Safe reports that the U.S. FDA substantially revised its cellphone radiation webpages around January 15, 2026, removing or reducing prior language that broadly reassured the public about safety. The article argues the new framing more closely reflects the FDA’s statutory responsibilities under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), emphasizing research, monitoring, and public information rather than definitive safety conclusions. It also links the change to a reported HHS announcement of a new study and portrays the update as a shift toward greater transparency, while noting some safety language may remain on the page.

RF Safe recounts a timeline of FTC actions and consumer guidance targeting phone “radiation shield” stickers/patches that claimed large reductions in exposure, arguing these products can create a false sense of security. The post cites the FTC’s February 2002 enforcement actions and consumer alert, including references to Good Housekeeping Institute testing that reportedly found the products did not reduce exposure. RF Safe also claims it warned about such scams earlier (late 1990s), framing this as its own account rather than an FTC-attributed origin story.

RF Safe promotes its QuantaCase (also called TruthCase) as a leading “anti-radiation” phone case for 2026, emphasizing a directional shielding design intended to deflect RF energy away from the body. The article argues the product aligns with consumer-safety guidance such as keeping phones away from the body and using hands-free modes, and it claims RF Safe’s earlier advocacy influenced FTC/FCC warnings about ineffective or counterproductive shielding products. It cites comparisons, user reviews, and an “independent” 2017 TV review as support, but presents limited verifiable technical detail in the excerpt.

RF Safe presents itself as an RF exposure advocacy and education project promoting “RF exposure literacy,” safer-use habits, and updated safety frameworks beyond thermal-only assumptions. The post highlights RF Safe’s tools, including a SAR comparison database based on FCC SAR data, a public research viewer described as containing 4,000+ peer-reviewed studies, and its “TruthCase”/editorial standards. It argues that non-thermal biological interactions are reported in experimental literature and that compliance with current SAR limits does not necessarily reflect optimal real-world exposure outcomes.

RF Safe argues that “no effect” (null) findings in RF research should be treated as informative constraints rather than dismissed, within its S4–Mito–Spin mechanistic framework. The post claims biological and exposure heterogeneity can produce nonlinear, tissue- and signal-dependent outcomes, making null results an expected pattern under many study conditions. It references a WHO-commissioned systematic review on RF-EMF and oxidative stress biomarkers as concluding the evidence is of “very low certainty,” citing bias, heterogeneity, and exposure/measurement limitations.

RF Safe publishes a commentary disputing Media Bias Fact Check’s (MBFC) labeling of RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility.” The post argues MBFC mischaracterized RF Safe’s content as overstating evidence about cell phones and health, claiming RF Safe generally uses cautious, study-referencing language (e.g., “associations,” “potential risks”) and avoids asserting direct human causation. It also points to RF Safe disclaimers that the site is educational and not medical advice, and highlights its research library linking to primary studies such as NTP and Ramazzini animal findings.

This PubMed-listed paper argues that the U.S. regulatory framework for radiofrequency radiation (RFR) from wireless technologies is outdated, lacks adequate oversight and enforcement, and has not been meaningfully updated since 1996. It contends that FCC exposure limits focus on short-term, high-intensity effects and do not address long-term, low-intensity exposures, with insufficient safeguards for children, pregnancy, and other vulnerable groups. The authors also discuss alleged regulatory capture, gaps in monitoring and compliance, and propose reforms including independent research, updated safety limits, and stronger pre- and post-market surveillance.

RF Safe publishes a rebuttal to Media Bias Fact Check (MBFC) after MBFC labeled RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility.” The article argues MBFC made factual errors about RF Safe’s research links and ownership/funding, and says MBFC has not corrected the entry despite requests. RF Safe also defends its framing of non-thermal RF/EMF effects as precautionary and grounded in peer-reviewed literature, while criticizing what it characterizes as superficial fact-checking.

RF Safe argues that many “anti-radiation” phone cases use misleading marketing (e.g., fabric-swatch tests, vague “FCC tested” claims) and that some designs may cause phones to increase transmit power if they interfere with antennas. The article provides a checklist of red flags (magnets/metal plates, detachable shields, unclear orientation instructions) and emphasizes behavioral steps to reduce RF exposure. It promotes RF Safe’s QuantaCase as a “directional shielding” design intended to reduce exposure on the body-facing side while avoiding signal blockage that could prompt higher power output.

RF Safe argues that celebrity-branded mobile services (citing reported plans for “Beast Mobile” and the announced “Trump Mobile”) could normalize near-body, all-day phone use—especially among children—and therefore carry ethical responsibility for scaled RF exposure. The piece cites legal and scientific developments (including the 2021 Environmental Health Trust v. FCC decision, the U.S. NTP animal studies, and a WHO-commissioned systematic review) to claim the evidence base has “moved decisively” toward concern about long-term RF-EMF effects. It also promotes a proposed mechanistic framework ("S4–Mito–Spin") and suggests shifting indoor connectivity toward Li‑Fi (IEEE 802.11bb) as a harm-reduction approach.

RF Safe argues that recent WHO-linked evidence reviews have moved beyond a “thermal-only” safety narrative and that policy should respond with stronger protections. The post cites a 2025 WHO-commissioned systematic review in Environment International as concluding with “high certainty” that RF-EMF increases malignant heart schwannomas and brain gliomas in male rats, and references a 2025 corrigendum upgrading certainty for reduced pregnancy rates after male RF exposure in animal experiments. It also points to U.S. FCC rules being rooted in 1996-era assumptions and references a U.S. appellate court remand requiring the FCC to better address non-cancer harms and impacts on children and long-term exposure. The article advocates for the “Clean Ether Act” and promotes RF Safe’s proposed “S4–Mito–Spin” mechanism framework as a non-thermal explanatory model.

RF Safe argues that children’s everyday wireless exposure is primarily shaped by policy choices (laws, agency guidance, research mandates, and procurement practices) rather than by technology alone. The post promotes an “Act Now” hub that offers coordinated advocacy actions aimed at changing federal and local rules, increasing research and oversight, and shifting indoor connectivity toward alternatives such as Li‑Fi. It frames current governance as outdated and restrictive, particularly around local authority and federal agency accountability.

This magazine article discusses the rising incidence of thyroid cancer and raises the possibility of an association with increased smartphone use and related RF EMF exposure near the head and neck. It characterizes EMF exposure from personal electronics as a growing public health concern. The piece calls for more research, monitoring, and public awareness, and mentions precautionary measures.

This animal experiment assessed GSM-modulated 3.5 GHz RF exposure in male Wistar rats and reported hormonal, oxidative, and histological changes consistent with testicular impairment. RF exposure was associated with lower testosterone, LH, and FSH, higher oxidative stress (increased MDA and TOS), and degenerative testicular histology. Coenzyme Q10 supplementation partially mitigated several reported changes. The authors caution against generalizing these results to FR1 5G NR signals and call for further research.

This in vitro study examined strictly non-thermal, GSM-like 3.5 GHz RF-EMF exposure in cultured mouse dorsal root ganglion neurons for 1–24 hours. The authors report time-dependent reductions in cell viability alongside increased ROS and changes consistent with mitochondria-mediated apoptosis (e.g., Bax/caspase-3 up, cytochrome c release, Bcl-2 down) and increased p75NTR. They conclude these findings provide mechanistic evidence of peripheral neuronal vulnerability to mid-band RF exposure and call for further in vivo research.

This study reports measurements of electric field intensity (E) and magnetic flux density (B) from electric vehicles (inside driver/passenger seats during driving) and EV supply equipment (near chargers during charging) up to 400 kHz in and around Chennai. E and B inside EVs and E around EVSEs were reported to be within ICNIRP/IEEE guideline limits. However, B around certain EVSE positions reportedly exceeded a general public threshold (~200 T), and a preliminary FEM analysis suggested relatively higher fields at charging infrastructure. The authors call for further research on long-term health impacts and recommend policy actions to mitigate exposure.

RF Safe argues that the established term “electromagnetic hypersensitivity” (EHS) should not be replaced by the newer label “EMR Syndrome,” claiming the rebranding fragments research and weakens advocacy. The piece frames EHS as a continuity-based concept tied to reported symptoms in EMF-rich environments and emphasizes practical mitigation via engineering, architecture, and policy—especially to reduce children’s exposure. It uses “EMR Syndrome” narrowly to describe what it portrays as an ideological, anti-technology pattern that blocks solutions rather than a physiological condition.